Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.
Previously, he worked at The Wall Street Journal, The Star-Ledger of New Jersey, and New York Newsday. It’s best to reach him by email.
Journalistic ethics: Ed adheres to the standards outlined in the STAT ethics policy. STAT is committed to truth, accuracy, impartiality, and transparency in our reporting.
